prostatilen

drug obtained from the prostate of cattle; possesses an antiinflammatory, antibacterial, immunomodulating effect, improves urination, stimulates the copulative & generative functions; used for treatment of prostatitis in man

Networked: 17 relevant articles (6 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Al'-Shukri, S Kh: 3 articles (11/2006 - 11/2003)
2.	Gorbachev, A G: 3 articles (11/2006 - 11/2003)
3.	Kuz'min, I V: 3 articles (11/2006 - 11/2003)
4.	Belousov, V Ia: 2 articles (11/2006 - 09/2005)
5.	Borovets, S Iu: 2 articles (11/2006 - 09/2005)
6.	Gomon, O N: 2 articles (07/2006 - 03/2005)
7.	Malinin, V V: 1 article (07/2012)
8.	Savateeva-Liubimova, T N: 1 article (07/2012)
9.	Sivak, K V: 1 article (07/2012)
10.	Chushkin, K A: 1 article (11/2006)

Related Diseases

1.	Prostatitis 11/01/1991 - "Prostatilen proved effective for chronic prostatitis because it is tolerable, induces no side effects, beneficial in combinations with other modalities in management of this persistent and prone to recurrences disease." 05/01/1997 - "Normalization of hemostasis seems to be one of the factors of prostatilen therapeutic efficacy in chronic prostatitis. " 05/01/1997 - "Prostatilen effects on hemostasis were studied in 120 intact and 240 chronic prostatitis rats, 34 patients with chronic prostatitis. " 01/01/1995 - "Prostatilen was shown to be capable of normalization of immunity status of the chronic prostatitis patients thus lowering the microbial index of the cultured prostate secretion microorganisms. " 11/01/1991 - "[The use of prostatilen in treating patients with chronic prostatitis]."
2.	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/01/2006 - "This suggests possibility of suppository prostatilen use not only as an alternative for expensive drugs but also in combination with them in treatment of initial prostatic adenoma." 11/01/2006 - "[Prostatilen treatment of prostatic adenoma]." 09/01/2005 - "The authors review the experience with prostatilen treatment gained in the urological clinic of the St-Petersburg State Medical University and analyze treatment outcomes for 96 patients with benign prostatic hyperplasia (BPH) aged from 51 to 89 years. " 09/01/2005 - "[Prostatilen effects on voiding disorders in patients with benign prostatic hyperplasia]." 03/01/2005 - "We studied the effects of 30-day injections of sulpyride and treatment with Prostatilen on the development of prostatic hyperplasia and LPO in rats. "
3.	Pyelonephritis 07/01/1997 - "The ability of prostatilen to initiate normalization of hemocoagulation and immunity is thought to be an essential factor of its therapeutic efficacy in chronic pyelonephritis." 11/01/2003 - "Prostatilen was used in 1115 patients with chronic pyelonephritis and prostatitis. "
4.	Teratozoospermia 07/01/2022 - "Prostatilen AC compared to Prostatilen had a statistically significant and clinically significantly superior efficacy in relation to initially impaired sperm parameters (improve of sperm motility, restoration of morphologically normal sperm, decrease in forms of abnormal spermatozoa with head, acrosome or neck pathology). " 07/01/2022 - "In patients who received the drug Prostatilen AC the number of abnormal forms of spermatozoa decreased by 12.4% (After therapy - 55.57%), and in the comparison group (drug Prostatilen) by 6.5% (After therapy - 58.90%) with significant decrease in forms of abnormal spermatozoa with head, acrosome, or neck pathology for Prostatilen AC compared to control. "
5.	Dysuria 11/01/1991 - "Prostatilen is indicated in: chronic prostatitis, prostatic adenoma stage I, normospermatogenic and toxic sterility, interoceptive copulative dysfunction, dysuria. "

Related Drugs and Biologics

1.	Suppositories (Vaginal Suppositories)
2.	Peptides (Polypeptides)
3.	Zinc
4.	Dimethyl Sulfoxide (DMSO)
5.	Hemostatics (Antihemorrhagics)
6.	Antioxidants
7.	Turpentine
8.	Proteins (Proteins, Gene)
9.	Immunologic Factors (Immunomodulators)
10.	Ceruloplasmin (Ferroxidase)

Related Therapies and Procedures

1.	Therapeutics
2.	Injections